期刊文献+

选择性脾切除调整门静脉血流预防活体肝移植小肝综合征 被引量:1

Modulation of portal vein hemodynamics by selective splenectomy to prevent small-for-size syndrome in living donor liver transplantation
原文传递
导出
摘要 目的探讨选择性脾切除对活体肝移植(LDLT)受者术中门静脉血流(PVF)及术后小肝综合征(SFSS)发生率的影响。方法回顾性分析2007年9月至2008年3月26例LDLT术中PVF监测资料。对PVF〉250ml/(min·100g)者,术中同期行脾切除术;PVF%250ml/min(100g)者不行脾切除,分析选择性脾切除对PVF的影响及是否可以预防SFSS的发生。结果脾切除8例,切脾后PVF较切脾前明显降低(P〈O.01)。脾切除及未行脾切除的患者均无SFSS发生。其中脾切除患者(8例)供肝重占受者体重比显著低于未行脾切除患者(18例)(P=0.044),PVF显著高于未行脾切除患者(P〈O.01)。结论根据LDLT术中PVF监测数据,选择性脾切除可显著降低高门静脉灌注患者的PVF,对术后SFSS有预防作用。 Objective To investigate the effects of selective splenectomy on modulation of portal vein flow and prevention of small-for-size syndrome (SFSS) in living donor liver transplantation. Methods Twenty six recipients who received LDLT from September 2007 to March 2008 were reviewed. The data of the portal vein flow of these recipients were collected during the operation. Simultaneous splenectomy was performed in patients with portal blood flow ~250 ml/(min · 100g). No splenectomy was performed when the portal blood flow was less than 250 ml/(min · 100g). The effect of selective splenectomy on modulation of portal vein flow and whether splenectomy prevented the occurrence of SFSS were analyzed. Results The portal vein flow decreased significantly after splenectomy in 8 patients who received splenectomy (P^0.01), No SFSS occurred in the patients with or without splenectomy. Actual graft-to-recipient weight ratio (GRWR) of patients with splenectomy was significantly smaller than those with no splenectomy (P= 0. 044). The portal vein flow of patients with splenectomy was much higher than those with no splenectomy (P〈0. 01). Conclusion According to the portal blood flow, selective splenectomy in LDLT decreased the portal vein flow and prevented the incidence of SFSS.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2011年第11期909-911,共3页 Chinese Journal of Hepatobiliary Surgery
基金 天津市科委重点项目(08ZCZDSF03100)
关键词 活体肝移植 小肝综合征 门静脉血流 脾切除 Living donor liver transplantation Small-for-size syndrome Portal vein flow Splenectomy
  • 相关文献

参考文献17

  • 1任志刚,周琳,郑树森.小肝综合征(SFSS)的研究进展[J].中华肝胆外科杂志,2011,17(5):437-440. 被引量:7
  • 2Troisi R, de Hemptinne B. Clinical relevance of adapting por- tal vein flow in living donor liver transplantation in adult pa- tients[J]. Liver Transpl, 2003,9 :S36-S41.
  • 3Imura S, Shimada M, Ikegami T, et al. Strategies for impro- ving the outcomes in the use of small-for-size grafts in living donor liver transplantation[J]. J Hepatobiliary Pancreat Surg, 2008,15 : 102-110.
  • 4Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-porto- caval shunts for inflow modulation on the outcome of small for- size grafts in living donor liver transplantation [J]. Am J Transplant. 2005,5 : 1397-1404.
  • 5汪闻夕,范上达.活体肝移植的理论和实践[J].中华肝胆外科杂志,2002,8(5):259-261. 被引量:4
  • 6Morioka D, Egawa H, Kasahara M, et al. Outcomes of adult- to-adult living donor liver transplantation., a single institution's experience with 335 consecutive cases[J]. Ann Surg, 2007, 245: 315-325.
  • 7Tanaka K, Yamada T. Living donor liver transplantation in Japan and Kyoto University: what can we learn[J]? J Hepa tol, 2005,42:25-28.
  • 8Lauro A, Diago Uso T, Quintini C, et al. Adult-to-adult liv- ing donor liver transplantation using left lobes: the importance of surgical modulations on portal graft inflow[J]. Transplant Proc, 2007,39.- 1874-1876.
  • 9Florman S, Miller CM. Live donor liver transplantation[J]. Liver Transpl, 2006,12:499-510.
  • 10Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hy- perperfusion or small-for-size syndrome [J]. Am J Surg Pathol, 2006,30 : 986-993.

二级参考文献80

共引文献9

同被引文献32

  • 1Yoshimura N,Okajima H, Ushigome H, et al. Current statusof organ transplantation in Japan and worldwide. Surg Today, 2010, 40(6): 514-25.
  • 2Raut V, Uemoto S. Management of ABO-incompatible living- donor liver transplantation past and present trends. Surg Today, 2011,41 (3) :317-322.
  • 3Tanabe M,Kawachi S, Obara H, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest, 2010, 40(10): 943-949.
  • 4Wu J, Ye S, Xu X, et al. Recipient outcomes after ABO- incompatible liver transplantation; a systematic review and meta-analysis. PLoS One, 2011,6(1 ) : e16521.
  • 5HantoDW, Fecteau AH, Alonso MH, et al. ABO- incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl, 2003,9(1) :22-30.
  • 6Mor E, Skerrett D, Manzarbeitia C, et aI. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation, 1995,59(7) :986-990.
  • 7Kozaki K, Egawa H, Kasahara M, et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial, 2005, 9 (4) : 285-291.
  • 8Raut V, Mori A, Kaido T, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation, 2012,93(1) :99-105.
  • 9Usuda M, Fujimori K, Koyamada N, et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO- incompatible living-related liver transplantation. Transplantation, 2005, 79(1) : 12-16.
  • 10Goralczyk AD,Obed A, Schnitzbauer A, et al. Adult living donor liver transplantation with ABO-incompatible grafts: a german single center experience. J Transplant, 2009, 2009: 759581. Epub 2010 Feb 3.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部